The Venture Codex Logo

The Venture Codex

Overview

Sector-focused private equity firm investing in energy, food, and media.

Founded

1984

Deals ยท 12mo

0

Stage focus

Series B
Series C

Geographic focus

China
United States

Sector focus

Finance
Financial Services
Impact Investing

Investment portfolio

8rounds
NAMEDATESIZE
OncoC4
Oct 2025Participated
$50 MSeries B
Osteal Therapeutics
Jun 2024Participated
$50 MSeries D
Osteal Therapeutics
Sep 2023Participated
$23 MSeries C
Porton Advanced Solutions
Aug 2022Participated
$80 MSeries B
Osteal Therapeutics
Mar 2022Led
$30 MSeries B
GenFleet Therapeutics
Jan 2022Participated
$79 MSeries C
Sagimet Biosciences
Feb 2021Participated
$80 MOther Equity
OncoImmune
Sep 2020Led
$56 MSeries B
OncoC4
Oct 2025Participated
$50 MSeries B
Osteal Therapeutics
Jun 2024Participated
$50 MSeries D
Osteal Therapeutics
Sep 2023Participated
$23 MSeries C
Porton Advanced Solutions
Aug 2022Participated
$80 MSeries B
Osteal Therapeutics
Mar 2022Led
$30 MSeries B
GenFleet Therapeutics
Jan 2022Participated
$79 MSeries C
Sagimet Biosciences
Feb 2021Participated
$80 MOther Equity
OncoImmune
Sep 2020Led
$56 MSeries B
8
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

HM Capital: 8 funding rounds are recorded in the selected participation categories.All available history.
HM Capital: 8 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B22
Series C+03
Other Equity01

Monthly Deal Activity

HM Capital: 8 deals are recorded across 74 months.All available history.
HM Capital: 8 deals are recorded across 74 months. All available history
MonthDeals
Sep '201
Oct '200
Nov '200
Dec '200
Jan '210
Feb '211
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '221
Feb '220
Mar '221
Apr '220
May '220
Jun '220
Jul '220
Aug '221
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '231
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '241
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '251
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

HM Capital: Health & Life Sciences is the largest displayed sector by deal count (8 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

HM Capital: Health & Life Sciences is the largest displayed sector by deal count (8 deals). All available history
SectorDeals
Health & Life Sciences8
Manufacturing1

Deal Size Distribution

HM Capital: 8 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

HM Capital: 8 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M1
$25M-$50M1
$50M-$100M6
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

HM Capital: United States has the largest recorded deal count among the displayed regions (6 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

HM Capital: United States has the largest recorded deal count among the displayed regions (6 deals). All available history
RegionDeals
United States6
China2
HM Capital: 20 co-investors are shown, with Johnson & Johnson Innovation sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

HM Capital: Led accounts for 25% and participating for 75% of round participation.All available history.
HM Capital: Led accounts for 25% and participating for 75% of round participation. All available history
CategoryDeals (count)Share (%)
Led225%
Participating675%
HM Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
HM Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead2100%
Co-led00%

Team

Eric C. Neuman

Partner & Managing Director

John Muse

Chairman